GUIDE TO UNDERSTANDING PSYCHIATRIC EFFECTS OF SINOPHARM VACCINE
DOI:
https://doi.org/10.53555/0yww7k73Keywords:
psychiatric adverse events, psychiatric adverse effects, vaccine adverse effects study, adverse events from vaccine, immunization adverse effect, what is a vaccine adverse event, adverse vaccine response, neuropsychiatric adverse events, vaccine psychiatric symptoms, COVID-19 virus, COVID vaccines, Sinopharm COVID-19 vaccine, psychosis after covid-19 vaccination, vaccine psychiatric symptoms, psychiatric symptoms of covid-19, is mental illness a side effect of covid-19 vaccine, sinopharm covid-19 vaccine, acute psychosis after covid-19 vaccination, vaccine psychiatric symptoms.Abstract
The COVID-19 pandemic posed serious threats to society, necessitating the development of vaccinations. Vaccination efforts faced challenges, including potential systemic and psychological side effects. Reports indicate that many recipients of the COVID-19 vaccination experienced mild side effects such as fatigue and injection site pain, while a minority reported more severe mental health issues like anxiety and panic attacks. Notably, these effects were typically temporary, subsiding within days. A cross-sectional study of 500 people who received the Sinopharm COVID-19 vaccine found that 13 participants experienced mild psychiatric symptoms after the first and second doses of Sinopharm vaccine, assessing their psychiatric responses after each dose and during follow-ups at six months and one-year post-immunization. Results showed that eight participants reported psychological symptoms after the first dose, including anxiety and dizziness. Monitoring after the second dose revealed 5 mild psychological adverse reactions, and no psychiatric issues like bipolar disorder or depression were observed at the six-month mark. However, some participants did experience migraines and episodic headaches, linked to other factors. A year later, follow-up assessments found no new vaccine-related psychiatric concerns, confirming the vaccine's safety.
References
Works Cited
1. Hengbo Zhu, Li Wei & Ping Niu. 02 March 2020. "the novel coronavirus outbreak in Wuhan, China." Global Health Research and Policy volume 5, Article number: 6.
2. Joint statement by ILO, FAO, IFAD and WHO. 13 October 2020. "Impact of COVID-19 on people's livelihoods, their health and our food systems."
3. Yong-Bo Zheng 1, 2,†, Jie Sun 1,3,†, Lin Liu 1,†, Yi-Miao Zhao 4,5, Wei Yan 1, Kai Yuan 1, Si-Zhen Su 1, Zheng-An Lu 1, Yue-Tong Huang 1, Lin Liu 4,5, Na Zeng 4,5,6, Xi-Mei Zhu 1, Yi-Miao Gong 1, Xiao Lin 1, Shi-Qiu Meng 4, Samuel Yeung Shan Wong 7, Mao-Sh. 2021 . "COVID-19 VacciCOVID-19 Vaccine-Related Psychological Stress Among General Public in Chinane-Related Psychological Stress Among General Public in China." Front Psychiatry. 2021 Dec 7; introduction .
4. Balasubramanian, Ilambaridhi. Volume 71, May 2022. "Psychiatric adverse reactions to COVID-19 vaccines: A rapid review of published case reports." Asian Journal of Psychiatry.
5. Garcia-Alanis M, Morales-Cardenas M, Toapanta-Yanchapaxi LN, et al. Psychological and psychiatric events following immunization with five different vaccines against SARS-CoV-2. Vaccines (Basel) 2022; 10:1297. doi: 10.3390/vaccines10081297. [DOI] [PMC free article] [PubMed] [Google Scholar][Ref list]
6. Seungeun Ryoo 1, Miyoung Choi 1, Nam-Kyong Choi 2,3, Hyoung-Shik Shin 2,4, Jun Hee Woo 2,5, Byung-Joo Park 2,5, Sanghoon Oh. 2024 Mar 28. "Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review." Osong Public Health Res Perspect 111(5).
7. Ilambaridhi Balasubramanian 1, Abdul Faheem 1, Susanta Kumar Padhy 1, Vikas Menon 2. 2022. "Psychiatric adverse reactions to COVID-19 vaccines: A rapid review of published case reports." Asian J Psychiatr Abstract.
8. Maris Taube, Alise Alma Lesiņa. 21 January 2025. "Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series." Front. Psychiatry , 21 January 2025 from 6 conclusion.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Population Therapeutics and Clinical Pharmacology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.